Comparison Overview
Sandoz Australia & New Zealand

Sandoz Australia & New Zealand
North Sydney , 2060, AU
Last Update: 29/03/2026
Sandoz Australia & New Zealand is an affiliate of Sandoz AG (SIX: SDZ; OTCQX: SDZNY), the global leader in generic and biosimilar medicines with a growth strategy driven by its Purpose: pioneering access for patients. More than 20,000 people of 100 nationalities work to...

Alkem Laboratories Ltd.
Lower Parel, Alkem House , Mumbai, IN, 400013
Last Update: 01/04/2026
A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It wa...
Compliance Ranges Comparison

Sandoz Australia & New Zealand







Alkem Laboratories Ltd.






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Sandoz Australia & New Zealand in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Alkem Laboratories Ltd. in 2026.
Incident History - Sandoz Australia & New Zealand (X = Date, Y = Severity)
Sandoz Australia & New Zealand cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Alkem Laboratories Ltd. (X = Date, Y = Severity)
Alkem Laboratories Ltd. cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Sandoz Australia & New Zealand

Alkem Laboratories Ltd.
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.